Article info
Multiple sclerosis
Research paper
Extended interval dosing of natalizumab in multiple sclerosis
- Correspondence to Professor EM Frohman, Department of Neurology and Neurotherapeutics, University of Texas Southwestern School of Medicine, 5323 Harry Hines Blvd, Dallas, TX 75390, USA; Elliot.frohman{at}utsouthwesternen.edu
Citation
Extended interval dosing of natalizumab in multiple sclerosis
Publication history
- Received December 16, 2015
- Revised January 25, 2016
- Accepted February 6, 2016
- First published February 25, 2016.
Online issue publication
July 14, 2016
Article Versions
- Previous version (25 February 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/